GlaxoSmithKline : Le vaccin et le consumer de nouveau en haut de l’affiche
>Vaccins et Consumer tirent la croissance - GSK publiait hier en séance ses résultats du T2 2019. Ils se révélaient nettement supérieurs aux attentes. De nouveau tirés par la division Vaccins (Shingrix et Meningitis) et par un solide trimestre en OTC (+4% à tcc), le groupe a ainsi bénéficié d’un effet mix-produits favorable pour la marge. Cet effet a compensé en partie la décroissance d’Advair aux US (-61% à tcc) et une hausse sensible des frais de R&D (acquisition de...GlaxoSmithKline is a global healthcare company. Co.'s segments include: Pharmaceuticals; Vaccines; and Consumer Healthcare. The Pharmaceuticals segment is focused on developing new medicines in respiratory, HIV, oncology and immuno-inflammation, with discovery research exploring these and other areas. The Vaccines segment has a portfolio and pipeline of vaccines to help protect people throughout life. Co. delivers vaccines to people living in over 160 countries. The Consumer Healthcare segment develops and markets consumer-preferred brands in oral health, pain relief, respiratory, nutrition/gastro-intestinal and skin health.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.